Prometheus Biosciences In... (RXDX)
Prometheus Biosciences Statistics
Share Statistics
Prometheus Biosciences has 47.81M shares outstanding. The number of shares has increased by 0% in one year.
| 47.81M |
| 0% |
| 0% |
| n/a |
| n/a |
| 43 |
| n/a |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Valuation Ratios
The PE ratio is -31.52 and the forward PE ratio is null. Prometheus Biosciences's PEG ratio is -1.46.
| -31.52 |
| n/a |
| 656.18 |
| n/a |
| 6.61 |
| -35.47 |
| -1.46 |
Enterprise Valuation
Prometheus Biosciences has an Enterprise Value (EV) of 4.21B.
| 617.57 |
| -28.85 |
| -34.12 |
| -33.38 |
Financial Position
The company has a current ratio of 31.04, with a Debt / Equity ratio of 0.04.
| 31.04 |
| 31.08 |
| 0.04 |
| -0.2 |
| -0.23 |
| 0 |
Financial Efficiency
Return on Equity is -20.97% and Return on Invested Capital is -20.57%.
| -20.97% |
| -19.14% |
| -20.57% |
| $70,195.88 |
| $-1,461,360.82 |
| 97 |
| 0.01 |
| n/a |
Taxes
| -629K |
| 0.44% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is -0.49, so Prometheus Biosciences's price volatility has been lower than the market average.
| -0.49 |
| n/a |
| 184.19 |
| 109.6 |
| 84.04 |
| 1,217,911 |
Income Statement
In the last 12 months, Prometheus Biosciences had revenue of 6.81M and earned -141.75M in profits. Earnings per share was -3.49.
| 6.81M |
| 6.81M |
| -145.78M |
| -141.75M |
| -145.78M |
| n/a |
| -3.49 |
Balance Sheet
The company has 292.42M in cash and 29.54M in debt, giving a net cash position of 262.88M.
| 292.42M |
| 29.54M |
| 262.88M |
| -331.09M |
| 758.41M |
| 707.06M |
Cash Flow
In the last 12 months, operating cash flow was -123.25M and capital expenditures -2.7M, giving a free cash flow of -125.96M.
| -123.25M |
| -2.7M |
| -125.96M |
| -3.1 |
Margins
Gross margin is 100%, with operating and profit margins of -2140.96% and -2081.83%.
| 100% |
| -2140.96% |
| -2081.83% |
| -2081.83% |
| -2140.96% |
| -2140.96% |
| -1849.86% |
Dividends & Yields
RXDX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| -3.17% |
| -2.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 94.06 |
| 2 |